"Chill packs" self-administered olanzapine as psychiatric harm reduction for methamphetamine-induced psychosis: a narrative review of the existing evidence base. [PDF]
Ruedisueli I +6 more
europepmc +1 more source
Comparative Mortality Risk of Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Alzheimer's Disease: A Real‑World Retrospective Cohort Study with Treatment Effect Heterogeneity Analysis. [PDF]
Jiang C +9 more
europepmc +1 more source
Learning Outcomes That Maximally Differentiate Psychiatric Treatments. [PDF]
Strobl EV, Kim S.
europepmc +1 more source
Pharmacological Management, Safety, and Outcomes in Bipolar Disorder: An Integrated Narrative Review of Clinical and Translational Evidence. [PDF]
Bereda G.
europepmc +1 more source
Multi-objective optimization in population pharmacokinetic model selection and optimization: application of NSGA-II in pyDarwin. [PDF]
Li X +5 more
europepmc +1 more source
Seizures Risk Related to Atypical Antipsychotics: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System (FAERS). [PDF]
Zhao X +5 more
europepmc +1 more source
Quetiapine inhibits the oxidative phosphorylation in head and neck squamous cell carcinoma through suppressing NAT10-mediated ac4C modification. [PDF]
Du S, Mao M, Wang W, Xu X, Ye S, Xie L.
europepmc +1 more source
Trends in the Use of Atypical Antipsychotics Among Children and Adolescents With Bipolar Spectrum Disorders in Korea. [PDF]
Park KJ, Kim YJ, Jung E, Kim JY, Kim HW.
europepmc +1 more source
Preliminary Evidence on the Efficacy and Tolerability of Quetiapine in Dual Disorders: A Prospective, Multicentric, Real-World Study. [PDF]
Mosca A +15 more
europepmc +1 more source
Antipsychotics-Associated Allergic Reaction: A Case Report and Review of Literature. [PDF]
Sadeghi F +2 more
europepmc +1 more source

